United States · FDA National Drug Code directory
Rocklatan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70727-529_1972fd8e-f2ee-40d9-aa87-c7263b6d952e
- Product NDC
- 70727-529
- Form
- SOLUTION/ DROPS
- Composition / generic term
- netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
- Labeler
- Alcon Laboratories, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190312
- Source listing expiry
- 20271231
Source-listed ingredients
- NETARSUDIL MESYLATE — .2 mg/mL
- LATANOPROST — .05 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTIC · 70727-529-25
- 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1 BOTTLE, PLASTIC · 70727-529-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →